MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers
MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers
Recruiting · NCT06911008 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2026-09-24 | NCT06911008 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
| National Cancer Institute (NCI) | 3015 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic in Florida | Jacksonville | United States | 224 |